Description:
Velasof is a fixed-dose combination of Sofosbuvir, a hepatitis C virus (HCV) nucleotide anaVelasof is a potent antiviral therapy designed to treat chronic Hepatitis C virus (HCV) infection. It combines velpatasvir and sofosbuvir, which act by blocking essential viral enzymes to halt replication.
Suitable for all major HCV genotypes, Velasof offers high cure rates with a simplified once-daily dosage. It is especially valued for its safety, minimal side effects, and convenience in achieving sustained virologic response (SVR). alog NS5B polymerase inhibitor, and Velpatasvir, an HCV NS5A inhibitor.
Share your experience with our medical product. Write a review!
29 Sep 2025
Gut Health and Immunity: Why a Healthy Digestive System is Your First Line of Defense
When most people think of the immune system, they imagine white blood cells, vaccines, or medicines that protect the body from infections.
29 Sep 2025
The Future of Pain Relief: From Traditional Balms to Next-Gen Transdermal Patches
Pain is one of the most common reasons people seek medical attention, whether it’s muscle pain after a long day, joint pain due to arthritis, or chronic conditions that affect daily living.
23 Jun 2025
Summer Diet Tips to Prevent Acidity and Indigestion
As temperatures rise during the summer months, many individuals experience increased instances of acidity and indigestion. The combination of heat, dietary choices, and lifestyle habits can exacerbate
18 Jun 2025
Global Health Challenges and Solutions: A Focus on Emerging Diseases
In an increasingly interconnected world, emerging diseases present significant challenges to global health systems.
